+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cost effectiveness of testing for chlamydial infections in asymptomatic women



Cost effectiveness of testing for chlamydial infections in asymptomatic women



Medical Care 27(8): 833-841



Routine testing for Chlamydia trachomatis during gynecological visits, as well as treatment of those found positive, has been suggested as a preventive measure against the serious consequences of chlamydial genital infections, e.g., pelvic inflammatory disease (PID), infertility, and ectopic pregnancy. This article examines the cost and effectiveness of this practice. The study is based on a model that predicts how routine testing and treatment will affect the future number of cases of PID, infertility, and ectopic pregnancy. The costs of test and treatment are estimated, as are the savings resulting from prevention. Results indicate that although routine testing was not effective in reducing the overall morbidity caused by chlamydial infections, for women 18-22 years of age routine testing during regular gynecologic sessions can be a cost-effective personal health service.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007165575

Download citation: RISBibTeXText

PMID: 2502694

DOI: 10.2307/3765348


Related references

Test-of-cure for asymptomatic genital chlamydial infections in women. A cost-benefit analysis. Sexually Transmitted Diseases 19(3): 133-136, 1992

A comparison of cost-effectiveness of three protocols for diagnosis and treatment of gonococcal and chlamydial infections in women in Africa. Sexually Transmitted Diseases 30(5): 455-469, 2003

A cost-effectiveness evaluation of testing and treatment of Chlamydia trachomatis infection among asymptomatic women infected with Neisseria gonorrhoeae. Sexually Transmitted Diseases 29(9): 542-551, 2002

Test-of-Cure for Asymptomatic Genital Chlamydial Infections in Women. Sexually Transmitted Diseases 19(3): 133-136, 1992

Asymptomatic genital herpes simplex and chlamydial infections in pregnant women. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 409, 1989

Gonococcal and chlamydial genitourinary infections in symptomatic and asymptomatic adolescent women. Clinical Pediatrics 34(8): 419-423, 1995

Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. Sexually Transmitted Infections 77(4): 276-282, 2001

Prevalence of genital mycoplasmas in asymptomatic male partners of women diagnosed as having chlamydial infections. Journal of Infection and ChemoTherapy 20(2): 143-145, 2014

Chlamydial antibodies in semen: Search for silent chlamydial infections in asymptomatic andrological patients. Infection 24(4): 309-313, 1996

Value and cost effectiveness of double culture tests for diagnosis of ocular viral and chlamydial infections. British Journal of Ophthalmology 71(9): 673-675, 1987

Chlamydial and gonococcal infections in women seeking pregnancy testing at family-planning clinics. American Journal of Obstetrics and Gynecology 198(5): 502.E1-4, 2008

Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years. Journal of General Internal Medicine 31(11): 1338-1344, 2016

Parasitic infections in asymptomatic homosexual men prevalence risk factors and the cost effectiveness of screening strategies. Clinical Research 33(2 PART 2): 725A, 1985

Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis. Acta Obstetricia et Gynecologica Scandinavica 80(4): 300-306, 2001

Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis. Value in Health 4(3): 266-275, 2001